Literature DB >> 28978284

* Murine Model of Progressive Orthopedic Wear Particle-Induced Chronic Inflammation and Osteolysis.

Jukka Pajarinen1, Akira Nabeshima1, Tzu-Hua Lin1, Taishi Sato1, Emmanuel Gibon1, Eemeli Jämsen1, Laura Lu1, Karthik Nathan1, Zhenyu Yao1, Stuart B Goodman1,2.   

Abstract

Periprosthetic osteolysis and subsequent aseptic loosening of total joint replacements are driven by byproducts of wear released from the implant. Wear particles cause macrophage-mediated inflammation that culminates with periprosthetic bone loss. Most current animal models of particle-induced osteolysis are based on the acute inflammatory reaction induced by wear debris, which is distinct from the slowly progressive clinical scenario. To address this limitation, we previously developed a murine model of periprosthetic osteolysis that is based on slow continuous delivery of wear particles into the murine distal femur over a period of 4 weeks. The particle delivery was accomplished by using subcutaneously implanted osmotic pumps and tubing, and a hollow titanium rod press-fit into the distal femur. In this study, we report a modification of our prior model in which particle delivery is extended to 8 weeks to better mimic the progressive development of periprosthetic osteolysis and allow the assessment of interventions in a setting where the chronic particle-induced osteolysis is already present at the initiation of the treatment. Compared to 4-week samples, extending the particle delivery to 8 weeks significantly exacerbated the local bone loss observed with μCT and the amount of both peri-implant F4/80+ macrophages and tartrate-resistant acid phosphatase-positive osteoclasts detected with immunohistochemical and histochemical staining. Furthermore, systemic recruitment of reporter macrophages to peri-implant tissues observed with bioluminescence imaging continued even at the later stages of particle-induced inflammation. This modified model system could provide new insights into the mechanisms of chronic inflammatory bone loss and be particularly useful in assessing the efficacy of treatments in a setting that resembles the clinical scenario of developing periprosthetic osteolysis more closely than currently existing model systems.

Entities:  

Keywords:  chronic inflammation; macrophage; osteolysis; total joint replacement; wear particle

Mesh:

Substances:

Year:  2017        PMID: 28978284      PMCID: PMC5734159          DOI: 10.1089/ten.TEC.2017.0166

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  41 in total

1.  Bacterial pathogen-associated molecular patterns stimulate biological activity of orthopaedic wear particles by activating cognate Toll-like receptors.

Authors:  Edward M Greenfield; Michelle A Beidelschies; Joscelyn M Tatro; Victor M Goldberg; Amy G Hise
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

2.  NF-κB decoy oligodeoxynucleotide inhibits wear particle-induced inflammation in a murine calvarial model.

Authors:  Taishi Sato; Jukka Pajarinen; Tzu-hua Lin; Yasunobu Tamaki; Florence Loi; Kensuke Egashira; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2015-07-14       Impact factor: 4.396

3.  Effects of alendronate on particle-induced osteolysis in a rat model.

Authors:  Peter J Millett; Matthew J Allen; Mathias P G Bostrom
Journal:  J Bone Joint Surg Am       Date:  2002-02       Impact factor: 5.284

4.  Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia.

Authors:  Rong Deng; Joseph P Balthasar
Journal:  Blood       Date:  2006-11-28       Impact factor: 22.113

5.  Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placebo.

Authors:  Edward M Schwarz; Debbie Campbell; Saara Totterman; Allen Boyd; Regis J O'Keefe; R John Looney
Journal:  J Orthop Res       Date:  2003-11       Impact factor: 3.494

6.  Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis.

Authors:  Panagiotis Koulouvaris; Khanh Ly; Lionel B Ivashkiv; Mathias P Bostrom; Bryan J Nestor; Thomas P Sculco; P Edward Purdue
Journal:  J Orthop Res       Date:  2008-01       Impact factor: 3.494

7.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.

Authors:  Stacey R Dillon; Cindy Sprecher; Angela Hammond; Janine Bilsborough; Maryland Rosenfeld-Franklin; Scott R Presnell; Harald S Haugen; Mark Maurer; Brandon Harder; Janet Johnston; Susan Bort; Sherri Mudri; Joseph L Kuijper; Tom Bukowski; Pamela Shea; Dennis L Dong; Maria Dasovich; Francis J Grant; Luann Lockwood; Steven D Levin; Cosette LeCiel; Kim Waggie; Heather Day; Stavros Topouzis; Janet Kramer; Rolf Kuestner; Zhi Chen; Don Foster; Julia Parrish-Novak; Jane A Gross
Journal:  Nat Immunol       Date:  2004-06-06       Impact factor: 25.606

8.  Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles.

Authors:  Emily E Carmody; Edward M Schwarz; J Edward Puzas; Randy N Rosier; Regis J O'Keefe
Journal:  Arthritis Rheum       Date:  2002-05

9.  Characterization of macrophage polarizing cytokines in the aseptic loosening of total hip replacements.

Authors:  Eemeli Jämsen; Vesa-Petteri Kouri; Juri Olkkonen; Andrej Cör; Stuart B Goodman; Yrjö T Konttinen; Jukka Pajarinen
Journal:  J Orthop Res       Date:  2014-06-05       Impact factor: 3.494

10.  Betacellulin promotes cell proliferation in the neural stem cell niche and stimulates neurogenesis.

Authors:  María Victoria Gómez-Gaviro; Charlotte E Scott; Abdul K Sesay; Ander Matheu; Sarah Booth; Christophe Galichet; Robin Lovell-Badge
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

View more
  10 in total

1.  Notch signaling inhibition protects against LPS mediated osteolysis.

Authors:  Peeyush N Goel; Alexander J Egol; Yasaman Moharrer; Beatrix Brandfield-Harvey; Jaimo Ahn; Jason W Ashley
Journal:  Biochem Biophys Res Commun       Date:  2019-06-05       Impact factor: 3.575

2.  NFκB sensing IL-4 secreting mesenchymal stem cells mitigate the proinflammatory response of macrophages exposed to polyethylene wear particles.

Authors:  Tzuhua Lin; Yusuke Kohno; Jhih-Fong Huang; Monica Romero-Lopez; Jukka Pajarinen; Masahiro Maruyama; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2018-08-07       Impact factor: 4.396

3.  Suppression of NF-κB-induced chronic inflammation mitigates inflammatory osteolysis in the murine continuous polyethylene particle infusion model.

Authors:  Takeshi Utsunomiya; Ning Zhang; Tzuhua Lin; Yusuke Kohno; Masaya Ueno; Masahiro Maruyama; Ejun Huang; Claire Rhee; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2021-03-28       Impact factor: 4.396

4.  Interleukin-4 repairs wear particle induced osteolysis by modulating macrophage polarization and bone turnover.

Authors:  Jukka Pajarinen; Tzuhua Lin; Akira Nabeshima; Taishi Sato; Emmanuel Gibon; Eemeli Jämsen; Tahsin N Khan; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2020-12-19       Impact factor: 4.396

5.  Particle disease really does exist.

Authors:  Jukka Pajarinen; Jiri Gallo; Michiaki Takagi; Stuart B Goodman; Bengt Mjöberg
Journal:  Acta Orthop       Date:  2017-11-16       Impact factor: 3.717

Review 6.  Inflammation and Bone Repair: From Particle Disease to Tissue Regeneration.

Authors:  Stuart B Goodman; Jukka Pajarinen; Zhenyu Yao; Tzuhua Lin
Journal:  Front Bioeng Biotechnol       Date:  2019-09-19

7.  Different Effects of Intramedullary Injection of Mesenchymal Stem Cells During the Acute vs. Chronic Inflammatory Phase on Bone Healing in the Murine Continuous Polyethylene Particle Infusion Model.

Authors:  Takeshi Utsunomiya; Ning Zhang; Tzuhua Lin; Yusuke Kohno; Masaya Ueno; Masahiro Maruyama; Claire Rhee; Ejun Huang; Zhenyu Yao; Stuart B Goodman
Journal:  Front Cell Dev Biol       Date:  2021-03-19

8.  MiR-92a/KLF4/p110δ regulates titanium particles-induced macrophages inflammation and osteolysis.

Authors:  Zhenkang Wen; Sipeng Lin; Changchuan Li; Zhuji Ouyang; Zhong Chen; Shixun Li; Yuxi Huang; Wenqiang Luo; Zhongcan Zheng; Peidong Guo; Manyuan Kuang; Yue Ding
Journal:  Cell Death Discov       Date:  2022-04-13

9.  Sex differences in the therapeutic effect of unaltered versus NFκB sensing IL-4 over-expressing mesenchymal stromal cells in a murine model of chronic inflammatory bone loss.

Authors:  Huaishuang Shen; Junichi Kushioka; Masakazu Toya; Takeshi Utsunomiya; Hirohito Hirata; Ejun Elijah Huang; Masanori Tsubosaka; Qi Gao; Xueping Li; Victoria Teissier; Ning Zhang; Stuart B Goodman
Journal:  Front Bioeng Biotechnol       Date:  2022-08-15

10.  Titanium Porous Coating Using 3D Direct Energy Deposition (DED) Printing for Cementless TKA Implants: Does It Induce Chronic Inflammation?

Authors:  Dong Jin Ryu; Chung-Hee Sonn; Da Hee Hong; Kyeu Back Kwon; Sang Jun Park; Hun Yeong Ban; Tae Yang Kwak; Dohyung Lim; Joon Ho Wang
Journal:  Materials (Basel)       Date:  2020-01-19       Impact factor: 3.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.